Determinants of the combined use of external beam radiotherapy and brachytherapy for low‐risk, clinically localized prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|119|20|3619-3628

ISSN： 0008-543x

Source： CANCER, Vol.119, Iss.20, 2013-10, pp. : 3619-3628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Cancer of the Prostate Risk Assessment (CAPRA) score predicts biochemical recurrence in intermediate‐risk prostate cancer treated with external beam radiotherapy (EBRT) dose escalation or low‐dose rate (LDR) brachytherapy

By  

BJU INTERNATIONAL, Vol. 114, Iss. 6, 2014-12 ,pp. : 865-871

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factor Analysis of the Expanded Prostate Cancer Index Composite in a Patient Group after Primary (External Beam Radiotherapy and Permanent Iodine-125 Brachytherapy) and Postoperative Radiotherapy for Prostate Cancer

By  

Current Urology, Vol. 2, Iss. 3, 2009-01 ,pp. : 122-129

Karger

Access to resources Recommend Favorite

Is modern radiotherapy still viable?

By  

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 1, 2015-02 ,pp. : 125-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

ERECTILE FUNCTION AFTER BRACHYTHERAPY WITH EXTERNAL BEAM RADIATION FOR PROSTATE CANCER

By FUJIOKA H.   ISHIMURA T.   SAKAI Y.   FUJII T.   JO Y.   TAKENAKA A.   FUJISAWA M.  

Archives of Andrology, Vol. 50, Iss. 4, 2004-07 ,pp. : 295-301

Informa Healthcare

Access to resources Recommend Favorite

The rise and fall of prostate brachytherapy: Use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

By  

CANCER, Vol. 120, Iss. 14, 2014-07 ,pp. : 2114-2121

John Wiley & Sons Inc

Access to resources Recommend Favorite